Cemsidomide

DB18400InvestigationalSmall molecule

Cemsidomide: Overview.

Mechanism: Pharmacologically active on Zinc finger protein Aiolos and DNA-binding protein Ikaros
Curator reviewed
Formula / weight: C₂₈H₂₇N₃O₄ · 469.541 g/mol (avg)
Also known as: (3s)-3-(6-((4-(morpholin-4-ylmethyl)phenyl)methyl)-2-oxobenzo(cd)indol-1-yl)piperidine-2,6-dione · 2,6-piperidinedione, 3-(6-((4-(4-morpholinylmethyl)phenyl)methyl)-2-oxobenz(cd)indol-1(2h)-yl)-, (3s)-
Code names: CFT-7455

Resolves to

Compound

Structure

InChIKeyMUKCJOOKCZSQNW-DEOSSOPVSA-NSMILESO=C1N([C@H]2CCC(=O)NC2=O)C2=CC=C(CC3=CC=C(CN4CCOCC4)C=C3)C3=CC=CC1=C23

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cemsidomide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.